Comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation

The Agency for Healthcare Research and Quality (AHRQ) commissioned this report to review the evidence for the clinical effects and safety of radiofrequency catheter ablation (RFA) for the management of atrial fibrillation (AF). Over the past decade, RFA has rapidly evolved as a tool for managing AF...

Full description

Bibliographic Details
Main Author: Ip, Stanley
Corporate Authors: United States Agency for Healthcare Research and Quality, Tufts Evidence-based Practice Center
Format: eBook
Language:English
Published: [Rockville, MD Agency for Healthcare Research and Quality 2009], 2009
Series:Comparative effectiveness review
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02724nam a2200289 u 4500
001 EB000942948
003 EBX01000000000000000736538
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
100 1 |a Ip, Stanley 
245 0 0 |a Comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation  |h Elektronische Ressource  |c prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Tufts Medical Center Evidence-based Practice Center ; investigators, Stanley Ip ... [et al.] 
260 |a [Rockville, MD  |b Agency for Healthcare Research and Quality  |c 2009], 2009 
300 |a 1 PDF file (1 v. (various pagings  |b ill.) 
505 0 |a Includes bibliographical references 
653 |a Comparative Effectiveness Research 
653 |a Catheter Ablation 
653 |a Atrial Fibrillation / radiotherapy 
710 2 |a United States  |b Agency for Healthcare Research and Quality 
710 2 |a Tufts Evidence-based Practice Center 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Comparative effectiveness review 
500 |a Title from PDF t.p. (viewed Aug. 29, 2011). - "July 2009.". - "Contract no. 290-02-0022." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK43190  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a The Agency for Healthcare Research and Quality (AHRQ) commissioned this report to review the evidence for the clinical effects and safety of radiofrequency catheter ablation (RFA) for the management of atrial fibrillation (AF). Over the past decade, RFA has rapidly evolved as a tool for managing AF in select patients. This rapid evolution has been driven by an enhanced understanding of the triggers and etiology of AF and the development of advanced catheter and imaging technologies. After extensive discussion with AHRQ and the technical expert panel (TEP), the key questions to be addressed in this report are: 1) What is the effect of RFA on short- (6 to 12 months) and long- (>12 months) term rhythm control, rates of congestive heart failure, left atrial and ventricular size changes, rates of stroke, quality of life, avoiding anticoagulation, and readmissions for persistent, paroxysmal and long-standing persistent (chronic) atrial fibrillation? 2) What are the patient-level and intervention-level characteristics associated with RFA effect on short- and long-term rhythm control? 3) How does the effect of RFA on short- and long-term rhythm control differ among the various techniques or approaches used? 4) What are the short- and long-term complications and harms associated with RFA?